David Bullough, Ph.D.
VP, Preclinical Development, RaNA. Former Executive Director, Metabolic Diseases, Pfizer.
Former VP and Head of Pharmaceutical and Preclinical Development, Metabasis Therapeutics.
Alan D. Cherrington, Ph.D.
Professor of Molecular Physiology and Biophysics, Professor of Medicine, Turner Chair in Diabetes Research, Vanderbilt University Medical Center.
Past President, American Diabetes Association.
G. Alexander Fleming, MD
CEO, Kinexum. Former Head, Metabolic and Endocrine Drug Products, FDA.
Co-author, WHO Guide to Good Clinical Practice. Former member, ICH working group E-6, Good Clinical Practice.
Dr. Trevor Gibbs, FRCP, MRCGP, DCH, FFPM
Founder, ClinSentry Ltd. Chair, Cambridge Clinical Trials Unit Steering Committee.
Former Head, Clinical Development, Medical Affairs, Safety, Pharmacovigilance & Medical Governance, GSK.
Scott J. Hecker, Ph.D.
VP, Chemistry, Rempex. Former VP, Chemistry, Metabasis Therapeutics.
Former VP, Chemistry, Microcide Pharmaceuticals.
Former Group Leader, Antibiotic Drug Discovery, Pfizer.
Jay S. Magaziner, Ph.D., M.S.Hyg.
Professor of Epidemiology and Public Health, Chair and Division Head, Department of Epidemiology and Public Health, University of Maryland School of Medicine.